𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Newer antiviral agents and therapeutic approaches for chronic hepatitis b

✍ Scribed by Francis Y. Yao

Book ID
107540440
Publisher
Current Science Inc.
Year
2006
Tongue
English
Weight
188 KB
Volume
5
Category
Article
ISSN
1540-3416

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antiviral agents for hepatitis B
Antiviral agents for hepatitis B
✍ John L. Gerin πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 266 KB
Serum HBeAg quantitation during antivira
Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B
✍ Heijtink, Rudolf A.; Kruining, Johannes; Honkoop, Pieter; Kuhns, Mary C.; Hop, W πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 2 views

Hepatitis Be antigen (HBeAg) seroconversion is considered the principal short-term goal of antiviral therapy in chronic hepatitis B. To test whether the pre-and per-treatment HBeAg quantitation has a higher predictive value than that of hepatitis B virus DNA (HBV-DNA) quantitation for the outcome of

Antiviral strategies in chronic hepatiti
Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B Virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds
✍ Gilda Civitico; Yanyan Wang; Carolyn Luscombe; Naomi Bishop; Gilda Tachedjian; I πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 880 KB

## Abstract Primary duck hepatocyte (PDH) cultures, congenitally infected with the duck hepatitis B virus (DHBV), were grown on feeder cell layers of irradiated human embryonic lung fibroblasts and then exposed to a number of compounds with recognized or potential antiviral activity. These compound

Clearance of serum HBsAg and anti-HBs se
Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B
✍ Olivier Borgniet; Parviz Parvaz; CΓ©cile Bouix; Philippe Chevallier; Christian Tr πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 151 KB

## Abstract In this study, we have analyzed the evolution of serum HBsAg levels in 16 patients with chronic hepatitis B who showed an HBsAg seroconversion following antiviral therapy. The data showed that the clearance of serum HBsAg is slower than that of serum HBV DNA, which may reflect a slow ki